Clinical Trials Browser

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT05470491 2026-04-08

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

Phase 1/2 Recruiting

265 enrolled

Other hematologic neoplasm

Acquired Immunodeficiency Syndrome, Hematologic Neoplasms

NCT04150120 2026-04-06

eChildHealth

Phase NA Completed

720 enrolled

Congenital Abnormalities, Acquired Immunodeficiency Syndrome, Heart Defects, Congenital, Hirschsprung Disease, Neoplasms, Patient Compliance, Child Nutrition Disorders, Premature Birth

NCT02659930 2026-04-01

Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

Phase 1 Active not recruiting

62 enrolled

Sarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT04303117 2026-03-25

PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

Phase 1/2 Recruiting

80 enrolled

Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT05935644 2026-03-19

ORCHID-Miami

Phase NA Enrolling by invitation

30 enrolled

Acquired Immunodeficiency Syndrome, Depression, Papillomavirus Infections

NCT07468695 2026-03-12

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya

Phase NA Not yet recruiting

300 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT07209917 2026-02-23

ASHA-Health II

Phase NA Recruiting

420 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms, Infections, Papillomavirus Infections

NCT05413811 2026-02-17

ACT2

Phase NA Completed

180 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms

NCT07390916 2026-02-05

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS5 Rwanda

Phase NA Not yet recruiting

300 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT04941274 2026-01-23

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Phase 1/2 Recruiting

86 enrolled

Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT05411237 2026-01-23

Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma

Phase 3 Not yet recruiting

130 enrolled

Sarcoma

AIDS-related Kaposi sarcoma, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Clinical Trials

Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

eChildHealth

Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

ORCHID-Miami

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya

ASHA-Health II

ACT2

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS5 Rwanda

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma